{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T10:27:51Z","timestamp":1786703271060,"version":"build-2736575974"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T00:00:00Z","timestamp":1786665600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T00:00:00Z","timestamp":1786665600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Gastrointest Canc"],"DOI":"10.1007\/s12029-026-01568-x","type":"journal-article","created":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T09:32:41Z","timestamp":1786699961000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Beyond PERISCOPE II: Redesigning Peritoneal-Directed Treatment for Gastric Cancer"],"prefix":"10.1007","volume":"57","author":[{"given":"Eoghan","family":"Burke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,14]]},"reference":[{"key":"1568_CR1","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1002\/ijc.34780","volume":"154","author":"A Rijken","year":"2024","unstructured":"Rijken A, Pape M, Simkens GA, et al. Peritoneal metastases from gastric cancer in a nationwide cohort: incidence, treatment and survival. Int J Cancer. 2024;154:992\u20131002.","journal-title":"Int J Cancer"},{"key":"1568_CR2","doi-asserted-by":"publisher","first-page":"2280","DOI":"10.4240\/wjgs.v15.i10.2280","volume":"15","author":"SYA Ho","year":"2023","unstructured":"Ho SYA, Tay KV, Yang Y, et al. Systematic review of diagnostic tools for peritoneal metastasis in gastric cancer\u2014staging laparoscopy and its alternatives. World J Gastrointest Surg. 2023;15:2280\u201393.","journal-title":"World J Gastrointest Surg"},{"key":"1568_CR3","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1200\/JCO.22.02867","volume":"42","author":"B Rau","year":"2024","unstructured":"Rau B, Lang H, Koenigsrainer A, et al. Effect of hyperthermic intraperitoneal chemotherapy on cytoreductive surgery in gastric cancer with synchronous peritoneal metastases: the phase III GASTRIPEC-I trial. J Clin Oncol. 2024;42:146\u201356.","journal-title":"J Clin Oncol"},{"issue":"suppl 17","key":"1568_CR4","doi-asserted-by":"publisher","first-page":"LBA4001","DOI":"10.1200\/JCO.2024.42.17_suppl.LBA4001","volume":"42","author":"SE Al-Batran","year":"2024","unstructured":"Al-Batran SE, Lorenzen S, Riera J, et al. Effect of chemotherapy\/targeted therapy alone versus chemotherapy\/targeted therapy followed by radical surgical resection in limited-metastatic gastric or gastro-oesophageal junction adenocarcinoma: the IKF-575\/RENAISSANCE phase III trial. J Clin Oncol. 2024;42(suppl 17):LBA4001.","journal-title":"J Clin Oncol"},{"key":"1568_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(26)00144-0","author":"JSE Quik","year":"2026","unstructured":"Quik JSE, Vollebergh MA, Ret\u00e8l VP, et al. Systemic therapy, gastrectomy, cytoreductive surgery, and hyperthermic intraperitoneal chemotherapy versus systemic therapy alone for gastric cancer with limited peritoneal metastases (PERISCOPE II): final results of a multicentre, randomised, controlled, phase 3 trial. Lancet Oncol. 2026. https:\/\/doi.org\/10.1016\/S1470-2045(26)00144-0.","journal-title":"Lancet Oncol"},{"key":"1568_CR6","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1016\/j.annonc.2026.02.003","volume":"37","author":"YY Janjigian","year":"2026","unstructured":"Janjigian YY, Shitara K, Ajani JA, et al. Nivolumab plus chemotherapy as first-line treatment for advanced gastric, gastroesophageal junction, and esophageal adenocarcinoma: 5-year follow-up results from CheckMate 649. Ann Oncol. 2026;37:787\u201397.","journal-title":"Ann Oncol"},{"key":"1568_CR7","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1001\/jamaoncol.2026.1347","volume":"12","author":"C Yan","year":"2026","unstructured":"Yan C, Yang Z, Shi Z, et al. Intraperitoneal and intravenous paclitaxel plus S-1 for gastric cancer with peritoneal metastasis: a phase 3 randomized clinical trial. JAMA Oncol. 2026;12:732\u201340.","journal-title":"JAMA Oncol"},{"issue":"suppl 2","key":"1568_CR8","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1200\/JCO.2026.44.2_suppl.359","volume":"44","author":"M Senthil","year":"2026","unstructured":"Senthil M, Meja Aguilar L, Maithel SK, et al. Phase II trial of systemic therapy plus intraperitoneal paclitaxel in gastric\/GEJ cancer peritoneal carcinomatosis: STOPGAP trial. J Clin Oncol. 2026;44(suppl 2):359.","journal-title":"J Clin Oncol"},{"key":"1568_CR9","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1186\/s12885-023-10680-1","volume":"23","author":"M Senthil","year":"2023","unstructured":"Senthil M, Dayyani F. Phase II clinical trial of sequential treatment with systemic chemotherapy and intraperitoneal paclitaxel for gastric and gastroesophageal junction peritoneal carcinomatosis\u2014STOPGAP trial. BMC Cancer. 2023;23:209.","journal-title":"BMC Cancer"},{"issue":"suppl 16","key":"1568_CR10","first-page":"TPS4241","volume":"44","author":"M Senthil","year":"2026","unstructured":"Senthil M, Hong SC, Uboha NV, et al. A randomized phase II\/III trial of intraperitoneal paclitaxel plus systemic treatment versus systemic treatment alone in gastric carcinomatosis: STOPGAP II\u2014ECOG-ACRIN EA2234. J Clin Oncol. 2026;44(suppl 16):TPS4241.","journal-title":"J Clin Oncol"}],"container-title":["Journal of Gastrointestinal Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12029-026-01568-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12029-026-01568-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12029-026-01568-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T09:32:42Z","timestamp":1786699962000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12029-026-01568-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,14]]},"references-count":10,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1568"],"URL":"https:\/\/doi.org\/10.1007\/s12029-026-01568-x","relation":{},"ISSN":["1941-6636"],"issn-type":[{"value":"1941-6636","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,14]]},"assertion":[{"value":"29 July 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethical approval was not required for this project.","order":1,"name":"Ethics","label":"Ethics Approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing Interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"186"}}